SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - General Update - Inclusion Of Specialty Product ILUMETRI, (Tildrakizumab Injection) In Category B Of China'S National Reimbursement Drug List
General update - Inclusion of specialty product ILUMETRI, (Tildrakizumab Injection) in category B of China''s National Reimbursement Drug List SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
As per attached letter.
Sun Pharma share price declines as it revises bid to buy balance Taro stake
Stock market Today: Sun Pharma increased its bid to purchase the outstanding shares of its US subsidiary Taro Pharma from $38 per share to $43 per share in cash. This move is part of Sun Pharma's strategic plan, announced in May, to acquire 100% ownership of Taro. SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Update On Non Binding Indication Of Interest To Acquire Shares Of Taro Pharmaceutical Industries Ltd.
Update on Non binding indication of interest to acquire shares of Taro Pharmaceutical Industries Ltd.
Buy Sun Pharmaceutical Industries; target of Rs 1400 Sharekhan
Sharekhan is bullish on Sun Pharmaceutical Industries has recommended buy rating on the stock with a target price of Rs 1400 in its research report dated December 08, 2023. SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 (LODR)-Change in Management
Intimation of changes in Senior Management Personnel Sun Pharma concludes ESOP plan of former Ranbaxy employees and closes Trust
Enters into licensing agreement with Aclaris Therapeutics, a clinical-stage bio-pharmaceutical company focused on developing novel drugs for immuno-inflammatory diseases SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Licensing Agreement With Aclaris Therapeutics, Inc
Licensing agreement with Aclaris Therapeutics, Inc SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Intimation Of Closure Of Sun Pharma ESOP Trust
Intimation of closure of Sun Pharma ESOP Trust SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Response To Query On Volume Movement
Response to query on volume movement